CEO Nancy Stagliano (File photo, Neuron23)

Up­dat­ed: Neu­ron23 launch­es with $113M fi­nanc­ing and eyes dead set on De­nali and Bio­gen

A day af­ter an­nounc­ing two new funds worth $500 mil­lion, West­lake Vil­lage BioPart­ners are an­nounc­ing their lat­est com­pa­ny. And it’s a well-heeled neu­ro start­up, mak­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.